Health Canada is seeking feedback on a search portal being built to replace the existing Clinical...
Health Canada
U.S. FDA and Health Canada will be co-hosting a regional public consultation
The U.S. FDA and Health Canada will be co-hosting a regional public consultation on Wednesday, May...
Health Canada Changes Time for Keeping Clinical trial Records for Drugs and Natural Health Products
Health Canada is pleased to announce they have reduced the period for keeping clinical trial...
Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100)
Health Canada has released their new guidance document for clinical trial researchers to comply with Part C, Div 5 of the Food & Drug Regulations. Review the document here.
Opportunity to Comment on Draft (Step 2) ICH Guidance: E19 Optimization of Safety Data Collection
The Draft (Step 2) ICH Guidance: E19 Optimization of Safety Data Collection was released by the International Council for Harmonisation (ICH) Assembly and is posted in English only on the ICH website for information and comment. If you wish, you may provide comments...